Close Menu

Move It Around

While a Senate proposal will shrink the US National Science Foundation's 2012 by $162 million, it may give the agency some flexibility on how to spend that money, reports ScienceInsider. The Senate Appropriations Committee voted last week to allot $6.7 billion to NSF for fiscal year 2012 and the lawmakers are considering allowing NSF to shift $100 million from its research budget to its facilities budget.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.